{
  "trial_id": "NCT03273712",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, performance status (Karnofsky or Lansky Play Scale), disease type (neuroendocrine tumors, meningioma, neuroblastoma, medulloblastoma), prior treatments (surgery, chemotherapy, biologic therapy, targeted agent therapy, radiation therapy), somatostatin receptor status, life expectancy, absolute neutrophil count, platelet count, total bilirubin, AST (SGOT) levels, ALT (SGPT) levels, urinalysis results, serum creatinine levels, nuclear GFR, use of contraception, weight, ability to lie still for imaging.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Categorical",
          "performance status (Karnofsky or Lansky Play Scale)"
        ],
        [
          "Region of Enrollment",
          "disease type (neuroendocrine tumors, meningioma, neuroblastoma, medulloblastoma)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "prior treatments (surgery, chemotherapy, biologic therapy, targeted agent therapy, radiation therapy)",
        "somatostatin receptor status",
        "life expectancy",
        "absolute neutrophil count",
        "platelet count",
        "total bilirubin",
        "AST (SGOT) levels",
        "ALT (SGPT) levels",
        "urinalysis results",
        "serum creatinine levels",
        "nuclear GFR",
        "use of contraception",
        "weight",
        "ability to lie still for imaging."
      ]
    },
    "processed-gen-response": "Age, gender, performance status (Karnofsky or Lansky Play Scale), disease type (neuroendocrine tumors, meningioma, neuroblastoma, medulloblastoma), prior treatments (surgery, chemotherapy, biologic therapy, targeted agent therapy, radiation therapy), somatostatin receptor status, life expectancy, absolute neutrophil count, platelet count, total bilirubin, AST (SGOT) levels, ALT (SGPT) levels, urinalysis results, serum creatinine levels, nuclear GFR, use of contraception, weight, ability to lie still for imaging."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Performance Status (Karnofsky or Lansky), Absolute Neutrophil Count, Platelet Count, Total Bilirubin, AST (SGOT), ALT (SGPT), Urinalysis, Serum Creatinine, Nuclear GFR, Prior Treatments, Tumor Type, Tumor Stage,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Performance Status (Karnofsky or Lansky)",
        "Absolute Neutrophil Count",
        "Platelet Count",
        "Total Bilirubin",
        "AST (SGOT)",
        "ALT (SGPT)",
        "Urinalysis",
        "Serum Creatinine",
        "Nuclear GFR",
        "Prior Treatments",
        "Tumor Type",
        "Tumor Stage"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Performance Status (Karnofsky or Lansky), Absolute Neutrophil Count, Platelet Count, Total Bilirubin, AST (SGOT), ALT (SGPT), Urinalysis, Serum Creatinine, Nuclear GFR, Prior Treatments, Tumor Type, Tumor Stage"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Karnofsky Performance Status, Lansky Play Scale, Norfolk Quality of Life Questionnaire, Absolute Neutrophil Count, Platelet Count, Total Bilirubin, AST, ALT, Urinalysis, Serum Creatinine, Nuclear GFR, Tumor Type, Somatostatin Receptor Status, Prior Treatment, Performance Status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Karnofsky Performance Status",
        "Lansky Play Scale",
        "Norfolk Quality of Life Questionnaire",
        "Absolute Neutrophil Count",
        "Platelet Count",
        "Total Bilirubin",
        "AST",
        "ALT",
        "Urinalysis",
        "Serum Creatinine",
        "Nuclear GFR",
        "Tumor Type",
        "Somatostatin Receptor Status",
        "Prior Treatment",
        "Performance Status."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Karnofsky Performance Status, Lansky Play Scale, Norfolk Quality of Life Questionnaire, Absolute Neutrophil Count, Platelet Count, Total Bilirubin, AST, ALT, Urinalysis, Serum Creatinine, Nuclear GFR, Tumor Type, Somatostatin Receptor Status, Prior Treatment, Performance Status."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, Karnofsky performance status, Lansky Play Scale, weight, height, body mass index (BMI), race, ethnicity, neuroendocrine tumor type, tumor size, number of target lesions, somatostatin receptor expression, Norfolk Quality of Life Questionnaire score, absolute neutrophil count, platelet count, total bilirubin, AST (SGOT), ALT (SGPT), urinalysis results, serum creatinine, nuclear GFR, prior treatments (surgery, chemotherapy, biologic therapy, targeted agent therapy, radiation therapy), time since last treatment.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Karnofsky performance status",
        "Lansky Play Scale",
        "weight",
        "height",
        "body mass index (BMI)",
        "neuroendocrine tumor type",
        "tumor size",
        "number of target lesions",
        "somatostatin receptor expression",
        "Norfolk Quality of Life Questionnaire score",
        "absolute neutrophil count",
        "platelet count",
        "total bilirubin",
        "AST (SGOT)",
        "ALT (SGPT)",
        "urinalysis results",
        "serum creatinine",
        "nuclear GFR",
        "prior treatments (surgery, chemotherapy, biologic therapy, targeted agent therapy, radiation therapy)",
        "time since last treatment."
      ]
    },
    "processed-gen-response": "Age, sex, Karnofsky performance status, Lansky Play Scale, weight, height, body mass index (BMI), race, ethnicity, neuroendocrine tumor type, tumor size, number of target lesions, somatostatin receptor expression, Norfolk Quality of Life Questionnaire score, absolute neutrophil count, platelet count, total bilirubin, AST (SGOT), ALT (SGPT), urinalysis results, serum creatinine, nuclear GFR, prior treatments (surgery, chemotherapy, biologic therapy, targeted agent therapy, radiation therapy), time since last treatment."
  }
}